M&T Bank Corp Haemonetics Corp Transaction History

M&T Bank Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$51.81 - $118.56 $104,138 - $238,305	-2,010 Closed	0 $0
Q1 2021 May 06, 2021	SELL	$111.01 - $139.48 $198,485 - $249,390	-1,788 Reduced 47.08%	2,010 $222,000
Q4 2020 Feb 12, 2021	BUY	$88.75 - $119.95 $63,988 - $86,483	721 Added 23.43%	3,798 $451,000
Q3 2020 Nov 06, 2020	BUY	$75.65 - $93.58 $232,775 - $287,945	3,077 New	3,077 $268,000
Q2 2020 Jul 29, 2020	SELL	$84.96 - $118.91 $286,060 - $400,369	-3,367 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$74.34 - $121.82 $64,304 - $105,374	-865 Reduced 20.44%	3,367 $335,000
Q4 2019 Feb 07, 2020	BUY	$114.37 - $129.46 $11,780 - $13,334	103 Added 2.49%	4,232 $487,000
Q3 2019 Nov 12, 2019	BUY	$117.16 - $138.52 $73,225 - $86,575	625 Added 17.84%	4,129 $521,000
Q2 2019 Aug 12, 2019	BUY	$81.74 - $120.34 $286,416 - $421,671	3,504 New	3,504 $422,000

333

53.8M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.77B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.